Nicole Meisner-Kober

Nicole Meisner-Kober

Auto-generated profile, based on publicly available information

Nicole Meisner-Kober

Department of Biosciences and Medical Biology Paris Lodron University of Salzburg Salzburg Austria

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Open access
JNJoel Nordin
Joel Nordin
YLYi Lee
Yi Lee
PVPieter Vader
Pieter Vader
IMImre Mäger
Imre Mäger
HJHenrik J. Johansson
Henrik J. Johansson
OGOskar Gustafsson
Oskar Gustafsson
Extracellular vesicles (EVs) are natural nanoparticles that mediate intercellular transfer of RNA and proteins and are of great medical interest; serving as novel biomarkers and potential therapeutic agents. However, there is little consensus on the most appropriate method to isolate high-yield and high-purity EVs from various biological fluids. Here, we describe a systematic comparison between two protocols for EV purification: ultrafiltration with subsequent liquid chromatography (UF-LC) and differential ultracentrifugation (UC). A significantly higher EV yield resulted from UF-LC as compared to UC, without affecting vesicle protein composition. Importantly, we provide novel evidence that, in contrast to UC-purified EVs, the biophysical properties of UF-LC-purified EVs are preserved, leading to a different in vivo biodistribution, with less accumulation in lungs. Finally, we show that UF-LC is scalable and adaptable for EV isolation from complex media types such as stem cell media, which is of huge significance for future clinical applications involving EVs. Recent evidence suggests extracellular vesicles (EVs) as another route of cellular communication. These EVs may be utilized for future therapeutics. In this article, the authors compared ultrafiltration with size-exclusion liquid chromatography (UF-LC) and ultra-centrifugation (UC) for EV recovery.

25 April 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
WHWolf Heusermann
Wolf Heusermann
JHJustin Hean
Justin Hean
DTDominic Trojer
Dominic Trojer
ESEmmanuelle Steib
Emmanuelle Steib
SBStefan von Bueren
Stefan von Bueren
NMNicole C. Meisner-Kober
Nicole C. Meisner-Kober
Exosomes are nanovesicles released by virtually all cells, which act as intercellular messengers by transfer of protein, lipid, and RNA cargo. Their quantitative efficiency, routes of cell uptake, and subcellular fate within recipient cells remain elusive. We quantitatively characterize exosome cell uptake, which saturates with dose and time and reaches near 100% transduction efficiency at picomolar concentrations. Highly reminiscent of pathogenic bacteria and viruses, exosomes are recruited as single vesicles to the cell body by surfing on filopodia as well as filopodia grabbing and pulling motions to reach endocytic hot spots at the filopodial base. After internalization, exosomes shuttle within endocytic vesicles to scan the endoplasmic reticulum before being sorted into the lysosome as their final intracellular destination. Our data quantify and explain the efficiency of exosome internalization by recipient cells, establish a new parallel between exosome and virus host cell interaction, and suggest unanticipated routes of subcellular cargo delivery.

19 March 2013 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
LSLukas Stalder
Lukas Stalder
WHWolf Heusermann
Wolf Heusermann
LSLena Sokol
Lena Sokol
DTDominic Trojer
Dominic Trojer
JWJoel Wirz
Joel Wirz
NMNicole C Meisner‐Kober
Nicole C Meisner‐Kober
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 July 2007 in Nature Chemical Biology
Verified
Journal Article
Closed access
NMNicole-Claudia Meisner
Nicole-Claudia Meisner
MHMartin Hintersteiner
Martin Hintersteiner
KMKurt Mueller
Kurt Mueller
RBRoman Bauer
Roman Bauer
JSJan-Marcus Seifert
Jan-Marcus Seifert
Manfred AuerManfred Auer
Manfred Auer

18 September 2019 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
GCGiulia Corso
Giulia Corso
WHWolf Heusermann
Wolf Heusermann
DTDominic Trojer
Dominic Trojer
André GörgensAndré Görgens
André Görgens
ESEmmanuelle Steib
Emmanuelle Steib
NMNicole Meisner‐Kober
Nicole Meisner‐Kober
Extracellular vesicles (EV) convey biological information by transmitting macromolecules between cells and tissues and are of great promise as pharmaceutical nanocarriers, and as therapeutic per se. Strategies for customizing the EV surface and cargo are being developed to enable their tracking, visualization, loading with pharmaceutical agents and decoration of the surface with tissue targeting ligands. While much progress has been made in the engineering of EVs, an exhaustive comparative analysis of the most commonly exploited EV‐associated proteins, as well as a quantification at the molecular level are lacking. Here, we selected 12 EV‐related proteins based on MS‐proteomics data for comparative quantification of their EV engineering potential. All proteins were expressed with fluorescent protein (FP) tags in EV‐producing cells; both parent cells as well as the recovered vesicles were characterized biochemically and biophysically. Using Fluorescence Correlation Spectroscopy (FCS) we quantified the number of FP‐tagged molecules per vesicle. We observed different loading efficiencies and specificities for the different proteins into EVs. For the candidates showing the highest loading efficiency in terms of engineering, the molecular levels in the vesicles did not exceed ca 40–60 fluorescent proteins per vesicle upon transient overexpression in the cells. Some of the GFP‐tagged EV reporters showed quenched fluorescence and were either non‐vesicular, despite co‐purification with EVs, or comprised a significant fraction of truncated GFP. The co‐expression of each target protein with CD63 was further quantified by widefield and confocal imaging of single vesicles after double transfection of parent cells. In summary, we provide a quantitative comparison for the most commonly used sorting proteins for bioengineering of EVs and introduce a set of biophysical techniques for straightforward quantitative and qualitative characterization of fluorescent EVs to link single vesicle analysis with single molecule quantification.

1 January 2012 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
LYLisa E. Young
Lisa E. Young
AMAshleigh E. Moore
Ashleigh E. Moore
LSLena Sokol
Lena Sokol
NMNicole Meisner-Kober
Nicole Meisner-Kober
DDDan A. Dixon
Dan A. Dixon
Commonly observed in colorectal cancer is the elevated expression of the prostaglandin (PG) synthase COX-2. In normal intestinal epithelium, the COX-2 mRNA is targeted for rapid decay through the 3′-untranslated region (3′-UTR) adenylate- and uridylate (AU)-rich element (ARE), whereas in tumors ARE-mediated decay is compromised. Here we show that the COX-2 ARE can mediate degradation through microRNA (miRNA)-mediated regulation. We identified miR-16 to bind the COX-2 3′-UTR and inhibit COX-2 expression by promoting rapid mRNA decay. In colorectal cancer cells and tumors, miR-16 levels were decreased approximately twofold and miR-16 expression in cancer cells attenuated COX-2 expression and PG synthesis. The COX-2 ARE is also bound by the RNA-binding protein HuR. In colorectal cancer tumors, HuR is overexpressed and localized within the cytoplasm, where it promotes ARE-mRNA stabilization. Under conditions of HuR overexpression, miR-16 was unable to promote rapid mRNA decay through the COX-2 ARE. Ribonucleoprotein immunoprecipitation of HuR showed direct association with miR-16 that was reversed when cytoplasmic trafficking of HuR was inhibited. Furthermore, this interaction between HuR and miR-16 promoted the downregulation of miR-16. These new results identify miR-16 as a central posttranscriptional regulator of COX-2 and show the ability of elevated levels of HuR to antagonize miR-16 function. Along with insight into altered ARE-mediated mRNA decay observed in colorectal cancer, these findings provide a new explanation for tumor-derived loss of miR-16. Mol Cancer Res; 10(1); 167–80. ©2011 AACR.